Temozolomideresistanceinhighgradegliomas#br#

doi:10.3969/j.issn.1674-8115.2018.01.022

Abstract

Abstract: High grade gliomas are always the research focus in the field of neurosurgery due to their poor prognosis despite the current standard therapeutic regimen of surgical resection followed by radiation therapy and chemotherapy. Alkylating agent temozolomide has been established as the standard chemotherapy while its resistance inevitable during treatment. This phenomenon seriously influences the prognosis of patients suffering from high grade gliomas. This review aims to elucidate temozolomide chemoresistance mechanisms through three chapters including O6-methylguanine-DNA methyltransferase (MGMT) methylation, mismatch repair mutation and epigenetic regulation consisting of p21, chromatin and histone, Y-box binding protein-1 and microRNAs.

Key words: high&ensp, grade&ensp, glioma, &ensp, temozolomide, &ensp, resistance, &ensp, O6-methylguanine-DNA&ensp, methyltransferase, &ensp, mismatch&ensp, repair

WEI Xiang-yu, XIE Chao-ran, YOU Chao-guo, CHEN Zheng, ZHENG Xue-sheng . Temozolomideresistanceinhighgradegliomas#br#[J]. , 2018, 38(1): 117-.

[1]	XU Tongtong, RUAN Huitong. Effects of hydrogel microspheres loaded with interleukin-4 on neural functional recovery by modulating the immune microenvironment after stroke [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(9): 1161-1170.
[2]	CHEN Zixuan, LIU Min. Research progress on immune cell therapy in renal cell carcinoma [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(7): 916-925.
[3]	WANG Gaoming, CUI Ran, LI Yanjing, LIU Yingbin. Study on the mechanism of KRAS R68G secondary mutation-induced resistance to KRAS^G12D-targeted inhibitor MRTX1133 [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(6): 705-716.
[4]	YANG Na, LIU Junli, BAI Jing, YANG Siyi, HAN Jiming, ZHANG Huahua. HENMT1 promotes the proliferation and migration of gastric cancer by activating the PI3K-AKT-mTOR signaling pathway [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(6): 717-726.
[5]	LIANG Xiaoning, SHI Tingwang, CHEN Yunfeng. Pathogenic mechanisms and therapeutic advances of small colony variants [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(6): 784-791.
[6]	YANG Chendie, HU Changqing, YUAN He, TAY Guan Poh, AMUTI Abulikemu, ZHANG Ruiyan, WANG Xiaoqun. Association between insulin resistance and left ventricular remodeling after STEMI in patients without a history of diabetes mellitus [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(3): 292-300.
[7]	ZOU Peichen, LIU Hongyu, AIHEMAITI· Ayinazhaer, ZHU Liang, TANG Yabin, LEI Huimin. Metabolic profiling of lung cancer cells with acquired resistance to sotorasib [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(2): 138-149.
[8]	SUN Chenwei, HAI Wangxi, QU Qian, XI Yun. [¹⁸F]F-FMISO and [¹⁸F]F-FLT PET/CT dual-nuclide imaging for in vivo prediction of drug resistance in pancreatic cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(1): 60-68.
[9]	HAN Yishan, XU Ziqi, TAO Mengyu, FAN Guangjian, YU Bo. PRMT6 promotes the proliferation and migration of breast cancer cells [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(8): 999-1010.
[10]	ZHANG Yesheng, YANG Yijing, HUANG Yiwen, SHI Longyu, WANG Manyuan, CHEN Sisi. Research progress in immune cells regulating drug resistance of tumor cells in tumor microenvironment [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(7): 830-838.
[11]	HE Shuhang, GUO Shangchun, TAO Shicong. Advances in the study of neurovascular coupling in bone repair [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(3): 373-378.
[12]	CHEN Zixuan, LIU Min. Progress in mechanisms and treatment of sunitinib resistance in renal cell carcinoma [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(10): 1307-1315.
[13]	ZHOU Wanzhen, TENG Yincheng. Research progress of the role of non-canonical Wnt signaling pathway in ovarian cancer and its potential therapeutic implications [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(8): 1056-1063.
[14]	CUI Zhiyan, CHEN Yao, TAO Yue, SHEN Shuhong, LI Hui. Effects of PRPS1 I72 mutations on drug resistance in acute lymphoblastic leukemia and its mechanisms [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(8): 977-987.
[15]	MEI Yanqing, HAN Yujie, WENG Wenyun, ZHANG Lei, TANG Yujie. In vitro therapeutic effects and molecular mechanisms of targeted inhibition of CDK12/13 in high-grade gliomas [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(5): 545-559.